Streetbeat News

Equity Actions

SLB

On CNBC, Amy Raskin revealed that her firm has trimmed its position in Schlumberger N.V. (SLB). No specific reasons for the decision or details on the extent of the trimming were provided in the article.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 5:09 pm

NKE

Amy Raskin, on CNBC, has announced that her firm has trimmed its position in Nike, Inc. (NKE).

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 5:08 pm

UBER

On CNBC, Sarat Sethi revealed that he has reduced his investment in Uber Technologies, Inc. This could indicate a lack of confidence or a strategic portfolio adjustment.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 5:07 pm

CSCO

On CNBC, Sarat Sethi revealed that he has sold his position in Cisco Systems, Inc. This announcement could influence investor sentiment and potentially impact Cisco's stock price in the short term.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 5:06 pm

PFE

On CNBC, Josh Brown, a well-known financial analyst, announced that he has purchased shares of Pfizer, Inc. (PFE).

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 5:04 pm

TWLO

Twilio (NYSE:TWLO) received mixed ratings from 8 financial analysts in the past three months, with a shift towards a more neutral stance in the last 30 days. The average 12-month price target for TWLO is now $75.12, up 15.27% from the previous $65.17. Analysts from firms like Goldman Sachs, Needham, Wells Fargo, Piper Sandler, and JMP Securities have updated their ratings and price targets, reflecting their latest views on the company's performance. Twilio's financial health indicators such as market capitalization, revenue growth, net margin, ROE, ROA, and debt management are also discussed, providing a comprehensive picture of the company's current market standing.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 5:00 pm

LAZ

Lazard (NYSE:LAZ) has been the subject of diverse analyst opinions ranging from bullish to bearish over the last three months. The average 12-month price target for LAZ is $39.8, with a high of $45.00 and a low of $31.00, reflecting a 12.11% increase from the previous average of $35.50. Analysts from UBS, Wolfe Research, Goldman Sachs, and Morgan Stanley have updated their ratings and price targets, indicating a mixed outlook. Lazard's financial performance shows a decline in revenue growth by -27.99% as of September 30, 2023, a below-average net margin of 1.15%, and an ROE of 1.69%. The company's debt-to-equity ratio is high at 6.04, suggesting a reliance on borrowed funds.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 5:00 pm

JBL

Institutional holdings data from Quiver Quantitative shows hedge funds and asset managers, including Fidelity, Point72, and Whale Rock Capital Management, have increased their positions in Jabil Inc. (NYSE:JBL). Fidelity notably raised its stake by 15.86%. Jabil reported solid Q1 FY24 earnings with $8.4 billion in net revenue and provided guidance for Q2 FY24 with expected softer demand. Jabil is a leading global manufacturing services provider with a competitive edge in the EMS and DMS segments. The company's strategy focuses on growth through diversification, customer expansion, and strategic acquisitions. Jabil's management has been returning value to shareholders through share repurchases and dividends, with a recent authorization for a $2.5 billion share repurchase program. Management's compensation is heavily tied to performance, aligning with shareholder interests. Jabil's financial health is strong, with efficient operations, manageable debt, and significant free cash flow growth. A reverse discounted cash flow analysis suggests Jabil's stock is undervalued, with a 'fair' share price estimated at $157, indicating a potential investment opportunity.

Portfolio Pulse from Quiver Quantitative

January 09, 2024 | 4:36 pm

FTNT

Fortinet (NASDAQ:FTNT) has been rated by 21 analysts in the last three months, with a current average 12-month price target of $59.33, down from the previous $71.85. Ratings range from bullish to indifferent, with no bearish ratings. Recent analyst actions include both raised and lowered price targets and ratings, reflecting changes in market dynamics and company performance. Fortinet's financials show strong revenue growth, net margin, ROE, and ROA, but a high debt-to-equity ratio. The company is a cybersecurity vendor with a broad customer base and subscription-based revenue.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 4:01 pm

AZN

AstraZeneca (NASDAQ:AZN) is evaluated against its peers in the Pharmaceuticals industry, revealing it may be undervalued based on its lower P/E, P/B, and P/S ratios compared to the industry average. However, its ROE, EBITDA, gross profit, and revenue growth are below the industry average, indicating potential inefficiencies and challenges in profitability and sales volume growth. AstraZeneca's lower debt-to-equity ratio suggests a stronger financial position with less reliance on debt financing.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 4:00 pm